Farmashop

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Farmashop - overview

Established

1998

Location

Montevideo, -, Uruguay

Primary Industry

Retail

About

Coboe S. A. operates under name Farmacia Farmashop, a company that delivers a wide array of pharmaceutical and wellness products, focusing on health and beauty solutions for consumers throughout Uruguay. Founded in 1998 and headquartered in Montevideo, Uruguay, Coboe S.


A. specializes in retailing health and wellness products. The company was acquired by Linzor Capital Partners in January 2013 and moved its initial fund to a continuation fund in June 2025, enhancing its operational capacity and market reach. The current CEO is Martin Sorrosal.


Farmacia Farmashop specializes in a comprehensive range of pharmaceutical and wellness products, catering primarily to individual consumers seeking health and beauty solutions. The company’s core offerings encompass medications, personal care items, cosmetics, skincare, and wellness products, including both prescription and over-the-counter options. Farmashop operates within several geographical markets, providing its services through both online sales and physical retail locations across the region. Farmacia Farmashop generated revenue of USD 228.


68 mn in 2023, with an EBITDA of USD 31. 09 mn for the same year. Revenue is primarily derived from direct sales to consumers through e-commerce and in-store purchases, supported by loyalty programs and seasonal promotions. As part of its future growth strategy, Coboe S.


A. is focused on expanding its product line to include new wellness solutions and personal care items, with plans for launches in the next fiscal year. The company aims to penetrate additional markets in South America to broaden its consumer base. Recent funding from Linzor Capital Partners will support these initiatives, ensuring that the company can effectively scale operations and enhance its market presence.


Current Investors

Linzor Capital Partners

Primary Industry

Retail

Sub Industries

Drug Stores/Convenience Stores

Website

www.farmashop.com.uy

Verticals

E-commerce

Company Stage

Mature - Buyout

Total Amount Raised

Subscriber access only

Farmashop - timeline of key events

Blurred Background

Want to see the Timeline of Key Events?

Request a demo for full access to this profile.

Farmashop - financials

Fiscal Year EndedSep 30, 2018Sep 30, 2019Sep 30, 2020Sep 30, 2021Sep 30, 2022Sep 30, 2023
Revenue (USD)4,800,763,3615,373,054,1605,889,213,523---
% Revenue Growth (YoY)-11.9%9.6%---
EBITDA (USD)500,769,559602,131,758777,073,229---
Operating Income (USD)372,531,163467,910,668507,825,718---
Operating Margin7.8%8.7%8.6%---
% EBITDA Margin10.4%11.2%13.2%---
NET Income (USD)166,798,329253,120,637202,884,515---
% Net Margin3.5%4.7%3.4%---

Farmashop - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Secondary BuyoutCompletedFarmashop-
BuyoutCompletedFarmashop-

Displaying 1 - 2 of 2

Farmashop - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.